Abstract
Currently used clinical diagnostic imaging modalities, such as magnetic resonance imaging (MRI) and x-ray computed tomography (CT) provide predominantly anatomic information. CT images reflect x-ray attenuation distribution in the body, whereas MRI signals depend primarily on proton density and tissue relaxivity. In contrast to these predominantly anatomic modalities, positron emission tomography (PET) reflects tissue physiology and metabolism. Although PET has been used predominantly as a research tool, the clinical use of this technique for the detection, noninvasive characterization, and treatment planning of selected disease processes has been extensively studied in oncology, cardiology, and neurology. The author examined currently available literature to reassess the potential role of PET as a diagnostic tool in the following specific clinical situations: (1) the differentiation of radiation necrosis from tumor recurrence; (2) the characterization of the physiologic significance of coronary stenosis and the evaluation of the myocardial viability; and (3) the localization of the epileptogenic foci.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
